Alzheon, Inc.

Pharmaceutical company · Framingham, Massachusetts, United States

Alzheon, Inc. is a pharmaceutical company headquartered in Framingham, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $126 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Alzheon at a glance

Typepharmaceutical company

HeadquartersFramingham, Massachusetts, United States

Earliest incorporation on record2013

SEC industryPharmaceutical Preparations

SEC CIK1582636

What does Alzheon do?

Private fundraising reported to the SEC

14 Form D notices; the most recent reported $126.3 million sold (2025).

Frequently asked questions about Alzheon

Where is Alzheon headquartered?

Alzheon, Inc. is headquartered in Framingham, Massachusetts, United States.

What does Alzheon do?

Alzheon, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

When was Alzheon founded?

The earliest incorporation on record for Alzheon, Inc. is in 2013, according to public company registers.

Similar companies

Pulmatrix, Inc.Framingham, Massachusetts, United States
Xenetic Biosciences, Inc.Framingham, Massachusetts, United States
KalVista Pharmaceuticals, Inc.Framingham, Massachusetts, United States
LFB USA Inc.Framingham, Massachusetts, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences